Wall Street analysts expect that UnitedHealth Group Inc (NYSE:UNH) will post sales of $54.85 billion for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for UnitedHealth Group’s earnings, with estimates ranging from $54.15 billion to $55.38 billion. UnitedHealth Group reported sales of $48.72 billion in the same quarter last year, which indicates a positive year over year growth rate of 12.6%. The business is expected to report its next earnings results on Tuesday, April 17th.
On average, analysts expect that UnitedHealth Group will report full-year sales of $54.85 billion for the current year, with estimates ranging from $223.50 billion to $225.72 billion. For the next financial year, analysts anticipate that the business will report sales of $242.70 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter in the previous year, the business earned $2.11 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis.
A number of equities research analysts have recently weighed in on the company. Deutsche Bank lifted their price objective on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Jefferies Group reaffirmed a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research note on Friday, December 1st. Finally, Evercore ISI reaffirmed an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research note on Friday, January 12th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $243.22.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the sale, the director now directly owns 76,637 shares of the company’s stock, valued at $18,881,824.06. The disclosure for this sale can be found here. Insiders have sold a total of 53,396 shares of company stock valued at $12,262,067 over the last three months. 0.89% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Envestnet Asset Management Inc. lifted its holdings in UnitedHealth Group by 12.0% during the 4th quarter. Envestnet Asset Management Inc. now owns 201,102 shares of the healthcare conglomerate’s stock worth $44,336,000 after buying an additional 21,545 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in UnitedHealth Group by 4.2% during the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 595,802 shares of the healthcare conglomerate’s stock worth $131,351,000 after buying an additional 23,908 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd purchased a new stake in UnitedHealth Group during the 4th quarter worth about $20,817,000. Ashburton Jersey Ltd lifted its holdings in UnitedHealth Group by 60.3% during the 4th quarter. Ashburton Jersey Ltd now owns 1,923 shares of the healthcare conglomerate’s stock worth $424,000 after buying an additional 723 shares during the last quarter. Finally, Sawtooth Solutions LLC lifted its holdings in shares of UnitedHealth Group by 10.1% in the 4th quarter. Sawtooth Solutions LLC now owns 3,054 shares of the healthcare conglomerate’s stock valued at $673,000 after purchasing an additional 281 shares during the last quarter. 85.65% of the stock is owned by institutional investors.
Shares of UnitedHealth Group (NYSE UNH) opened at $226.66 on Wednesday. UnitedHealth Group has a 1 year low of $157.52 and a 1 year high of $250.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $219,650.00, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s payout ratio is 31.58%.
COPYRIGHT VIOLATION NOTICE: This report was originally posted by Stock Observer and is owned by of Stock Observer. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.thestockobserver.com/2018/02/21/54-85-billion-in-sales-expected-for-unitedhealth-group-inc-unh-this-quarter.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.